Connection

Giuseppe Curigliano to Neoplasm Metastasis

Back to Details
This is a "connection" page, showing publications Giuseppe Curigliano has written about Neoplasm Metastasis.
Giuseppe Curigliano
Connection Strength
0.728
Neoplasm Metastasis
  1. Biopsy confirmation of metastatic sites in breast cancer patients: clinical impact and future perspectives. Breast Cancer Res. 2014; 16(2):205.
    View in: PubMed
    Score: 0.416
  2. The role of histone deacetylase inhibitors in metastatic breast cancer. Breast. 2019 Feb; 43:130-134.
    View in: PubMed
    Score: 0.146
  3. Pharmacokinetic drug evaluation of ribociclib for the treatment of metastatic, hormone-positive breast cancer. Expert Opin Drug Metab Toxicol. 2017 May; 13(5):575-581.
    View in: PubMed
    Score: 0.131
  4. Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114): an open-label, randomised, phase 2 trial from the Elderly Task Force/Breast Cancer Group. Lancet Oncol. 2018 03; 19(3):323-336.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.